2017-2025 World Urological Cancer Therapeutics Drugs Market Research Report (by Product Type, End-User/Application and Regions/Countries)

December 2019 | 140 pages | ID: 2513A2E679F1EN
HeyReport

Abstracts

SUMMARY

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for Urological Cancer Therapeutics Drugs , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
Urological Cancer Therapeutics Drugs market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• Asia-Pacific (China, India, Japan, Southeast Asia etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

• Xofigo (radium Ra 223 dichloride)
• Jevtana (cabazitaxel)
• Inlyta (axitinib)
• Votrient (pazopanib hydrochloride)
• Sutent (sunitinib malate)
• Zytiga (abiraterone acetate)
• Xtandi (enzalutamide)
• Opdivo (nivolumab)
• Provenge (sipuleucel-T)

By End-User / Application

• Hospital
• Medical Research Laboratory
• Others

By Company

• Novartis
• Pfizer
• Johnson & Johnson
• AstraZeneca
• Astellas
• Bristol-Myers Squibb
• Abbott Laboratories
• Celgene Corporation
• Dendreon Corporation
• Ferring Pharmaceuticals
• GlaxoSmithKline plc
• Indevus Pharmaceuticals Inc
• Ipsen
• Roche Healthcare
• Sanofi S.A.

Contents

1 MARKET DEFINITION

1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
5.2 Regional Market Growth
  5.2.1 North America
  5.2.2 Europe
  5.2.3 Asia-Pacific
  5.2.4 South America
  5.2.5 Middle East & Africa

6 NORTH AMERICA MARKET

6.1 by Type
6.2 by End-Use / Application
6.3 by Regions

7 EUROPE MARKET

7.1 by Type
7.2 by End-Use / Application
7.3 by Regions

8 ASIA-PACIFIC MARKET

8.1 by Type
8.2 by End-Use / Application
8.3 by Regions

9 SOUTH AMERICA MARKET

9.1 by Type
9.2 by End-Use / Application
9.3 by Regions

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
10.2 by End-Use / Application
10.3 by Regions

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS

12.DYNAREX NOVARTIS

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Pfizer
12.3 Johnson & Johnson
12.4 AstraZeneca
12.5 Astellas
12.6 Bristol-Myers Squibb
12.7 Abbott Laboratories
12.8 Celgene Corporation
12.9 Dendreon Corporation
12.10 Ferring Pharmaceuticals
12.11 GlaxoSmithKline plc
12.12 Indevus Pharmaceuticals Inc
12.13 Ipsen
12.14 Roche Healthcare
12.15 Sanofi S.A.

13 PRICE OVERVIEW

13.1 Price Segment
13.2 Price Trend

14 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Urological Cancer Therapeutics Drugs Market and Growth by Type
Table Global Urological Cancer Therapeutics Drugs Market and Growth by End-Use / Application
Table Global Urological Cancer Therapeutics Drugs Revenue (Million USD) by Vendors (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Revenue Share by Vendors (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume (Volume) by Vendors (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global Urological Cancer Therapeutics Drugs Market (Million USD) by Type (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Share by Type (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume (Volume) by Type (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume Share by Type (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Share by End-Use / Application (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume Share by End-Use / Application (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market (Million USD) by Regions (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Share by Regions (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume (Volume) by Regions (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market Volume Share by Regions (2017-2019)
Table North America Urological Cancer Therapeutics Drugs Market (Million USD) by Type (2017-2019)
Table North America Urological Cancer Therapeutics Drugs Market Share by Type (2017-2019)
Table North America Urological Cancer Therapeutics Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table North America Urological Cancer Therapeutics Drugs Market Share by End-Use / Application (2017-2019)
Table North America Urological Cancer Therapeutics Drugs Market (Million USD) by Regions (2017-2019)
Table North America Urological Cancer Therapeutics Drugs Market Share by Regions (2017-2019)
Table Europe Urological Cancer Therapeutics Drugs Market (Million USD) by Type (2017-2019)
Table Europe Urological Cancer Therapeutics Drugs Market Share by Type (2017-2019)
Table Europe Urological Cancer Therapeutics Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Europe Urological Cancer Therapeutics Drugs Market Share by End-Use / Application (2017-2019)
Table Europe Urological Cancer Therapeutics Drugs Market (Million USD) by Regions (2017-2019)
Table Europe Urological Cancer Therapeutics Drugs Market Share by Regions (2017-2019)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market (Million USD) by Type (2017-2019)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market Share by Type (2017-2019)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific Urological Cancer Therapeutics Drugs Market Share by Regions (2017-2019)
Table South America Urological Cancer Therapeutics Drugs Market (Million USD) by Type (2017-2019)
Table South America Urological Cancer Therapeutics Drugs Market Share by Type (2017-2019)
Table South America Urological Cancer Therapeutics Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table South America Urological Cancer Therapeutics Drugs Market Share by End-Use / Application (2017-2019)
Table South America Urological Cancer Therapeutics Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Share by Regions (2017-2019)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market (Million USD) by Type (2017-2019)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Share by Type (2017-2019)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa Urological Cancer Therapeutics Drugs Market Share by Regions (2017-2019)
Table Global Urological Cancer Therapeutics Drugs Market (Million USD) Forecast by Regions (2020-2025)
Table Global Urological Cancer Therapeutics Drugs Market Share Forecast by Regions (2020-2025)
Table Global Urological Cancer Therapeutics Drugs Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global Urological Cancer Therapeutics Drugs Market Volume Share Forecast by Regions (2020-2025)
Table Global Urological Cancer Therapeutics Drugs Market (Million USD) Forecast by Type (2020-2025)
Table Global Urological Cancer Therapeutics DrugsMarket Share by Forecast Type (2020-2025)
Table Global Urological Cancer Therapeutics Drugs Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global Urological Cancer Therapeutics Drugs Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Novartis
Table Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Table Sales Revenue, Volume, Price, Cost and Margin of Johnson & Johnson
Table Sales Revenue, Volume, Price, Cost and Margin of AstraZeneca
Table Sales Revenue, Volume, Price, Cost and Margin of Astellas
Table Sales Revenue, Volume, Price, Cost and Margin of Bristol-Myers Squibb
Table Sales Revenue, Volume, Price, Cost and Margin of Abbott Laboratories
Table Sales Revenue, Volume, Price, Cost and Margin of Celgene Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of Dendreon Corporation
Table Sales Revenue, Volume, Price, Cost and Margin of Ferring Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of GlaxoSmithKline plc
Table Sales Revenue, Volume, Price, Cost and Margin of Indevus Pharmaceuticals Inc
Table Sales Revenue, Volume, Price, Cost and Margin of Ipsen
Table Sales Revenue, Volume, Price, Cost and Margin of Roche Healthcare
Table Sales Revenue, Volume, Price, Cost and Margin of Sanofi S.A.

List Of Figures

LIST OF FIGURES

Figure Global Urological Cancer Therapeutics Drugs Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global Urological Cancer Therapeutics Drugs Market (Million USD) and Growth Forecast (2020-2025)
Figure Global Urological Cancer Therapeutics Drugs Market Volume (Volume) and Growth Forecast (2020-2025)